2024 Q3 Form 10-Q Financial Statement

#000147793224004477 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2023 Q1
Revenue $97.10K $40.24K $0.00
YoY Change
Cost Of Revenue $42.68K $30.92K $0.00
YoY Change
Gross Profit $54.42K $9.321K $0.00
YoY Change
Gross Profit Margin 56.05% 23.16%
Selling, General & Admin $108.2K $80.00K
YoY Change 35.25% 46.92%
% of Gross Profit 1160.82%
Research & Development $0.00 $1.017K $33.85K
YoY Change -100.0% -97.0%
% of Gross Profit 0.0% 10.91%
Depreciation & Amortization $10.78K $11.12K
YoY Change -3.01% -62.29%
% of Gross Profit 115.69%
Operating Expenses $222.4K $245.4K $114.8K
YoY Change 162.68% 113.79% 36.73%
Operating Profit -$167.9K -$236.0K -$114.8K
YoY Change 98.39% 105.67% 36.73%
Interest Expense -$863.7K -$1.090M
YoY Change -20.76% -337.42%
% of Operating Profit
Other Income/Expense, Net $0.00 -$835.9K $0.00
YoY Change -100.0%
Pretax Income -$1.072M -$1.270M
YoY Change -15.59% -424.78%
Income Tax
% Of Pretax Income
Net Earnings -$361.0K -$1.072M -$1.209M
YoY Change -49.86% -11.35% -409.25%
Net Earnings / Revenue -371.79% -2663.89%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 2.240B shares 1.713B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change -100.0%
Cash & Equivalents $125.00 $0.00 $228.00
Short-Term Investments
Other Short-Term Assets $625.0K $630.0K
YoY Change -0.79%
Inventory
Prepaid Expenses
Receivables $33.53K
Other Receivables
Total Short-Term Assets $658.7K $625.0K $625.2K
YoY Change 46.18% -0.04% 9550.07%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $10.94K $57.09K
YoY Change -100.0% -80.84% -42.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.394M $4.657M $75.17K
YoY Change 8611.63% 6094.83% -47.94%
TOTAL ASSETS
Total Short-Term Assets $658.7K $625.0K $625.2K
Total Long-Term Assets $4.394M $4.657M $75.17K
Total Assets $5.053M $5.282M $700.4K
YoY Change 908.55% 654.12% 364.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $358.9K $240.0K
YoY Change 49.55% 1.21%
Accrued Expenses $501.3K $500.0K
YoY Change 0.25% -0.25%
Deferred Revenue
YoY Change
Short-Term Debt $2.627M $2.560M
YoY Change 2.62% 61.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.387M $6.420M $6.391M
YoY Change -3.65% 0.44% 92.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.387M $6.420M $6.391M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.420M $6.390M
YoY Change 0.46% 92.65%
SHAREHOLDERS EQUITY
Retained Earnings -$38.55M -$39.11M -$37.59M
YoY Change 3.28% 4.05% 7.92%
Common Stock $2.253M $2.154M $1.573M
YoY Change 20.09% 36.94% 7.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$333.9K -$1.138M -$5.691M
YoY Change
Total Liabilities & Shareholders Equity $5.053M $5.282M $700.4K
YoY Change 908.55% 654.12% 364.22%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$361.0K -$1.072M -$1.209M
YoY Change -49.86% -11.35% -409.25%
Depreciation, Depletion And Amortization $10.78K $11.12K
YoY Change -3.01% -62.29%
Cash From Operating Activities -$67.85K -$125.7K
YoY Change -46.01% 32.82%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $67.85K $126.2K
YoY Change -46.24% 24.84%
NET CHANGE
Cash From Operating Activities -$67.85K -$125.7K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $67.85K $126.2K
Net Change In Cash $0.00 $534.00
YoY Change -100.0% -91.76%
FREE CASH FLOW
Cash From Operating Activities -$67.85K -$125.7K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$67.85K -$125.7K
YoY Change -46.01% 32.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1061793 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001338929
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3500000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2024420237 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2153936721 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
600000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
603200 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-52047
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
AUTHENTIC HOLDINGS, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3746201
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
50 Division Street
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Somerset
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08873
CY2024Q1 dei City Area Code
CityAreaCode
732
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
695-4389
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2240073721 shares
CY2024Q1 us-gaap Revenues
Revenues
40240 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
30919 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
9321 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58904 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55300 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
136143 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11503 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
49294 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
14113 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1017 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33850 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
245358 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
114766 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-236037 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-114766 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-779967 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1046847 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27823 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
77949 usd
CY2023Q1 us-gaap Financing Interest Expense
FinancingInterestExpense
37589 usd
CY2024Q1 ahro Interest Expense Related Parties
InterestExpenseRelatedParties
5821 usd
CY2023Q1 ahro Interest Expense Related Parties
InterestExpenseRelatedParties
10059 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-835914 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1094495 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-1071951 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1209261 usd
CY2024Q1 ahro Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
2041785065 shares
CY2023Q1 ahro Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
1557397662 shares
CY2024Q1 ahro Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.001
CY2023Q1 ahro Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.001
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-205538 usd
CY2024Q1 ahro Reclassification Amount
ReclassificationAmount
0 usd
CY2024Q1 ahro Stock Issued During Perod Value Conversion Of Notes
StockIssuedDuringPerodValueConversionOfNotes
83813 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
79980 usd
CY2024Q1 ahro Extinquishment Of Derivative Liabilities
ExtinquishmentOfDerivativeLiabilities
24061 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071951 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1137757 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4516802 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35000 usd
CY2023Q1 ahro Adjustment Shares Issued Amount
AdjustmentSharesIssuedAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1209261 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5691063 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-1071951 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1209261 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
779967 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1046847 usd
CY2024Q1 ahro Gain Loss On Conversion Of Convertible Debt
GainLossOnConversionOfConvertibleDebt
-27823 usd
CY2023Q1 ahro Gain Loss On Conversion Of Convertible Debt
GainLossOnConversionOfConvertibleDebt
0 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21297 usd
CY2024Q1 us-gaap Depreciation
Depreciation
10783 usd
CY2023Q1 us-gaap Depreciation
Depreciation
11118 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
125360 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
35450 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
527 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
59070 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
24714 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-67847 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125670 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-1808 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
48230 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
35000 usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
83980 usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12500 usd
CY2024Q1 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
43000 usd
CY2023Q1 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 usd
CY2024Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
30474 usd
CY2024Q1 ahro Repayment Of Advances From Related Parties
RepaymentOfAdvancesFromRelatedParties
41325 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25000 usd
CY2024Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
16000 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67847 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
126204 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
534 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-306 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
83813 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2023Q2 ahro Finite Lived Intangible Asset Estimate Useful Life
FiniteLivedIntangibleAssetEstimateUsefulLife
P10Y
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39110719 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38038768 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071951 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1209261 usd
CY2024Q1 ahro Working Capital Deficit
WorkingCapitalDeficit
-5794657 usd
CY2023Q4 ahro Working Capital Deficit
WorkingCapitalDeficit
-4998581 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
240853 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
240853 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
229915 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
219132 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10938 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21721 usd
CY2024Q1 us-gaap Depreciation
Depreciation
10783 usd
CY2023Q1 us-gaap Depreciation
Depreciation
11118 usd
CY2024Q1 ahro Amortization For The Intangible Assets
AmortizationForTheIntangibleAssets
5155096 usd
CY2023 ahro Amortization For The Intangible Assets
AmortizationForTheIntangibleAssets
5155096 usd
CY2024Q1 ahro Less Accumulated Amortization
LessAccumulatedAmortization
-571490 usd
CY2023 ahro Less Accumulated Amortization
LessAccumulatedAmortization
-383774 usd
CY2024Q1 ahro Amortization For The Intangible Assets Net
AmortizationForTheIntangibleAssetsNet
4645962 usd
CY2023 ahro Amortization For The Intangible Assets Net
AmortizationForTheIntangibleAssetsNet
4771322 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
125360 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2413019 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1633052 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
603200 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
600000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2153936721 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2024420237 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 ahro Unsecured Note Payable
UnsecuredNotePayable
99700 usd
CY2023Q4 ahro Unsecured Note Payable
UnsecuredNotePayable
99700 usd
CY2024Q1 ahro Accrued Interest
AccruedInterest
61497 usd
CY2023Q4 ahro Accrued Interest
AccruedInterest
60250 usd
CY2024Q1 us-gaap Other Notes Payable
OtherNotesPayable
161197 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
159950 usd
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1041413 usd
CY2024Q1 ahro Convertible Note Payable Discount
ConvertibleNotePayableDiscount
-15625 usd
CY2023Q4 ahro Convertible Note Payable Discount
ConvertibleNotePayableDiscount
-36921 usd
CY2024Q1 ahro Accrued Interestate
AccruedInterestate
341603 usd
CY2023Q4 ahro Accrued Interestate
AccruedInterestate
295986 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1367391 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1320858 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1633052 usd
CY2024Q1 us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
779967 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
2413019 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year One
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne
375525 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Two
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo
500700 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Three
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree
500700 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Four
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFour
500700 usd
CY2024Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Five
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFive
500700 usd
CY2024Q1 ahro Present Value Of Future Insurance Profits Amortization Expense Year Six
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearSix
500700 usd
CY2024Q1 ahro Present Value Of Future Insurance Profits Amortization Expense
PresentValueOfFutureInsuranceProfitsAmortizationExpense
2879025 usd
CY2024Q1 ahro Present Value Of Future Insurance Profits Amortization Expense Year Thereafter
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThereafter
1752450 usd
CY2024Q1 ahro Total Estimated Future Amortization
TotalEstimatedFutureAmortization
4631475 usd
CY2024Q1 ahro Net Cash Proceeds
NetCashProceeds
41325 usd
CY2023Q1 ahro Net Cash Proceeds
NetCashProceeds
48230 usd
CY2024Q1 ahro Advances From Related Parties Debt
AdvancesFromRelatedPartiesDebt
519454 usd
CY2023Q1 ahro Advances From Related Parties Debt
AdvancesFromRelatedPartiesDebt
560779 usd
CY2024Q1 ahro Related Party Transaction Amounts Of Promissory Note And Accrued Interest
RelatedPartyTransactionAmountsOfPromissoryNoteAndAccruedInterest
512313 usd
CY2024Q1 ahro Related Party Transaction Amounts Of Convertible Notes And Accrued Interest
RelatedPartyTransactionAmountsOfConvertibleNotesAndAccruedInterest
87693 usd
CY2024Q1 ahro Related Party Transaction Amounts Of Related Party Loans
RelatedPartyTransactionAmountsOfRelatedPartyLoans
276298 usd
CY2024Q1 ahro Related Party Transaction Amounts Of Total Related Parties Loans
RelatedPartyTransactionAmountsOfTotalRelatedPartiesLoans
876324 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
501250 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39241153 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38038768 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8240642 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7988141 usd
CY2024Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
8240642 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
7988141 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
39000000 usd
CY2024Q1 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s net operating loss carry forwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2019 through 2023 are subject to review by the tax authorities
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2433029215 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2433029215 shares
CY2024Q1 ahro Amount Proceeds From Secured Promissory Notes
AmountProceedsFromSecuredPromissoryNotes
29500 usd
CY2024Q1 ahro Promissory Notes Repayment Amount
PromissoryNotesRepaymentAmount
17500 usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
27494 usd

Files In Submission

Name View Source Status
ahro-20240331_cal.xml Edgar Link unprocessable
0001477932-24-004477-index-headers.html Edgar Link pending
0001477932-24-004477-index.html Edgar Link pending
0001477932-24-004477.txt Edgar Link pending
0001477932-24-004477-xbrl.zip Edgar Link pending
ahro-20240331.xsd Edgar Link pending
ahro_10q.htm Edgar Link pending
ahro_ex311.htm Edgar Link pending
ahro_ex312.htm Edgar Link pending
ahro_ex321.htm Edgar Link pending
ahro_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
ahro-20240331_def.xml Edgar Link unprocessable
ahro-20240331_pre.xml Edgar Link unprocessable
ahro-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ahro_10q_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending